# HCA Healthcare, Inc.: filings

HCA · NYSE · CIK 860730 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hca.md) · [Financials](/companies/hca/financials.md) · [Filings](/companies/hca/filings.md) · [Insiders](/companies/hca/insiders.md)

## Reports and events: 367 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1495, 8-K 268, SC 13G/A 64, 10-Q 54, 5 52, 3 48, 424B3 47, 144 43, FWP 27, 424B5 25, 10-K 18, DEFA14A 17, DEF 14A 15, UPLOAD 14, CORRESP 12, SC 13G 12, PX14A6G 10, ARS 9, 424B7 7, POSASR 7, S-8 6, 4/A 5, 8-K/A 5, EFFECT 5, S-3ASR 5, DEF 14C 4, PRE 14A 4, S-1 3, S-1/A 3, S-4 3, 3/A 2, PRE 14C 2, PRER14C 2, SCHEDULE 13G/A 2, 424B4 1, 8-A12B 1, 8-K12G3 1, CERTNYS 1, PX14A6N 1, RW 1, S-1MEF 1, S-4/A 1, S-8 POS 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:30 ET | [10-Q](/filings/0001193125-26-437871.md) | Quarterly report, period 2026-09-30 | 0001193125-26-437871 |
| 2026-10-27 | 07:17 ET | [8-K](/filings/0001193125-26-432665.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-432665 |
| 2026-07-29 | 16:10 ET | [8-K](/filings/0001193125-26-323731.md) | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-26-323731 |
| 2026-07-28 | 16:30 ET | [10-Q](/filings/0001193125-26-321077.md) | Quarterly report, period 2026-06-30 | 0001193125-26-321077 |
| 2026-07-24 | 07:45 ET | [8-K](/filings/0001193125-26-315151.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-315151 |
| 2026-07-14 | 07:40 ET | [8-K](/filings/0001193125-26-302539.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302539 |
| 2026-06-18 | 09:12 ET | [8-K](/filings/0001193125-26-275086.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-275086 |
| 2026-04-30 | 16:10 ET | [8-K](/filings/0001193125-26-197278.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-197278 |
| 2026-04-29 | 16:02 ET | [10-Q](/filings/0001193125-26-191444.md) | Quarterly report, period 2026-03-31 | 0001193125-26-191444 |
| 2026-04-28 | 16:20 ET | [8-K](/filings/0001193125-26-187155.md) | 5.07 Shareholder vote results | 0001193125-26-187155 |
| 2026-04-27 | 16:41 ET | [8-K](/filings/0001193125-26-182265.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-182265 |
| 2026-04-24 | 07:11 ET | [8-K](/filings/0001193125-26-174933.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-174933 |
| 2026-03-13 | 16:10 ET | [DEF 14A](/filings/0001193125-26-106142.md) | Proxy statement, period 2026-04-23 | 0001193125-26-106142 |
| 2026-02-25 | 16:43 ET | [8-K](/filings/0001193125-26-071880.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-071880 |
| 2026-02-10 | 19:47 ET | [SCHEDULE 13D](/filings/0001140361-26-004673.md) | Ownership report, active investor | 0001140361-26-004673 |
| 2026-02-10 | 16:27 ET | [10-K](/filings/0001193125-26-044769.md) | Annual report, period 2025-12-31 | 0001193125-26-044769 |
| 2026-01-27 | 07:12 ET | [8-K](/filings/0001193125-26-023323.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-023323 |
| 2025-10-31 | 16:15 ET | [8-K](/filings/0001193125-25-260809.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-260809 |
| 2025-10-30 | 16:30 ET | [10-Q](/filings/0001193125-25-258667.md) | Quarterly report, period 2025-09-30 | 0001193125-25-258667 |
| 2025-10-27 | 16:16 ET | [8-K](/filings/0001193125-25-251612.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-251612 |
| 2025-10-24 | 07:16 ET | [8-K](/filings/0001193125-25-249345.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-249345 |
| 2025-08-04 | 16:31 ET | [10-Q](/filings/0000950170-25-102056.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102056 |
| 2025-07-25 | 07:46 ET | [8-K](/filings/0000950170-25-098578.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-098578 |
| 2025-07-11 | 16:21 ET | [8-K](/filings/0001193125-25-158208.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-158208 |
| 2025-06-10 | 16:10 ET | [8-K](/filings/0001193125-25-138463.md) | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-25-138463 |
| 2025-05-01 | 16:30 ET | [10-Q](/filings/0000950170-25-061895.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061895 |
| 2025-04-29 | 16:39 ET | [8-K](/filings/0001193125-25-103953.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-103953 |
| 2025-04-25 | 07:48 ET | [8-K](/filings/0000950170-25-058334.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-058334 |
| 2025-03-14 | 16:27 ET | [DEF 14A](/filings/0001193125-25-054832.md) | Proxy statement, period 2025-04-24 | 0001193125-25-054832 |
| 2025-02-24 | 16:19 ET | [8-K](/filings/0001193125-25-033430.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-033430 |
| 2025-02-21 | 16:10 ET | [8-K](/filings/0001193125-25-031999.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-031999 |
| 2025-02-20 | 17:15 ET | [8-K](/filings/0001193125-25-030833.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-030833 |
| 2025-02-18 | 08:44 ET | [8-K](/filings/0001193125-25-028231.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028231 |
| 2025-02-14 | 18:26 ET | [10-K](/filings/0000950170-25-020134.md) | Annual report, period 2024-12-31 | 0000950170-25-020134 |
| 2025-01-24 | 07:40 ET | [8-K](/filings/0000950170-25-008608.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-008608 |
| 2024-10-31 | 16:30 ET | [10-Q](/filings/0000950170-24-119581.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119581 |
| 2024-10-25 | 07:38 ET | [8-K](/filings/0000950170-24-117215.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-117215 |
| 2024-08-12 | 16:35 ET | [8-K](/filings/0001193125-24-198927.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-198927 |
| 2024-08-08 | 16:57 ET | [8-K](/filings/0001193125-24-197060.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197060 |
| 2024-07-29 | 16:30 ET | [10-Q](/filings/0000950170-24-087322.md) | Quarterly report, period 2024-06-30 | 0000950170-24-087322 |
| 2024-07-23 | 08:03 ET | [8-K](/filings/0001193125-24-182591.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-182591 |
| 2024-05-02 | 16:30 ET | [10-Q](/filings/0000950170-24-052195.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052195 |
| 2024-04-30 | 16:27 ET | [8-K](/filings/0001193125-24-125204.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-125204 |
| 2024-04-26 | 08:01 ET | [8-K](/filings/0001193125-24-115857.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-115857 |
| 2024-03-15 | 16:24 ET | [DEF 14A](/filings/0001193125-24-069180.md) | Proxy statement, period 2024-04-25 | 0001193125-24-069180 |
| 2024-02-26 | 16:35 ET | [8-K/A](/filings/0001193125-24-046248.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-046248 |
| 2024-02-26 | 16:32 ET | [8-K](/filings/0001193125-24-046240.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-046240 |
| 2024-02-23 | 16:31 ET | [8-K](/filings/0001193125-24-044555.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-044555 |
| 2024-02-21 | 08:02 ET | [8-K](/filings/0001193125-24-040747.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-040747 |
| 2024-02-16 | 17:03 ET | [10-K](/filings/0000950170-24-016524.md) | Annual report, period 2023-12-31 | 0000950170-24-016524 |

Page 1 of 8. [Older](/companies/hca/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:36 ET. No prices; not investment advice.